PLK4
Summary: This gene encodes a member of the polo family of serine/threonine protein kinases. The protein localizes to centrioles, complex microtubule-based structures found in centrosomes, and regulates centriole duplication during the cell cycle. Three alternatively spliced transcript variants that encode different protein isoforms have been found for this gene. [provided by RefSeq, Jun 2010].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
polo like kinase 4 | MIM:605031 | Ensembl:ENSG00000142731 | HGNC:HGNC:11397 | PA36205 | 4q28.1 |
GO terms in PLK4
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IDA | GO:0004674 | protein serine/threonine kinase activity |
MF | ISS | GO:0004674 | protein serine/threonine kinase activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IPI | GO:0042802 | identical protein binding |
BP | TAS | GO:0000086 | G2/M transition of mitotic cell cycle |
BP | IDA | GO:0006468 | protein phosphorylation |
BP | IMP | GO:0007099 | centriole replication |
BP | TAS | GO:0010389 | regulation of G2/M transition of mitotic cell cycle |
BP | IDA | GO:0046601 | positive regulation of centriole replication |
BP | IMP | GO:0046601 | positive regulation of centriole replication |
BP | ISS | GO:0060707 | trophoblast giant cell differentiation |
BP | TAS | GO:0097711 | ciliary basal body-plasma membrane docking |
BP | ISS | GO:0098535 | de novo centriole assembly involved in multi-ciliated epithelial cell differentiation |
CC | IEA | GO:0001741 | XY body |
CC | ISS | GO:0005730 | nucleolus |
CC | IDA | GO:0005813 | centrosome |
CC | IDA | GO:0005814 | centriole |
CC | IDA | GO:0005829 | cytosol |
CC | TAS | GO:0005829 | cytosol |
CC | IEA | GO:0032154 | cleavage furrow |
CC | ISS | GO:0098536 | deuterosome |
Gene expression in normal tissue: PLK4
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in PLK4
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP2446 | Retinoblastoma (RB) in Cancer |
kegg | hsa04068 | FoxO signaling pathway - Homo sapiens (human) |
reactome | R-HSA-1640170 | Cell Cycle |
reactome | R-HSA-1852241 | Organelle biogenesis and maintenance |
reactome | R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition |
reactome | R-HSA-380259 | Loss of Nlp from mitotic centrosomes |
reactome | R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes |
reactome | R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centrosome |
reactome | R-HSA-380287 | Centrosome maturation |
reactome | R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes |
reactome | R-HSA-453274 | Mitotic G2-G2/M phases |
reactome | R-HSA-5617833 | Cilium Assembly |
reactome | R-HSA-5620912 | Anchoring of the basal body to the plasma membrane |
reactome | R-HSA-68877 | Mitotic Prometaphase |
reactome | R-HSA-68886 | M Phase |
reactome | R-HSA-69275 | G2/M Transition |
reactome | R-HSA-69278 | Cell Cycle, Mitotic |
reactome | R-HSA-8854518 | AURKA Activation by TPX2 |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD300 | Tozasertib | 3 |
iGMDRD887 | Compound 23 citrate | 3 |
iGMDRD506 | Fedratinib | 3 |
iGMDRD366 | PI-103 | 1 |
iGMDRD705 | Nakiterpiosin | 3 |
iGMDRD105 | Triptolide | 1 |
iGMDRD289 | Parthenolide | 4 |
iGMDRD52 | Rotenone | 3 |
iGMDRD255 | SB225002 | 1 |
iGMDRD123 | Isoevodiamine | 3 |
iGMDRD435 | BI-2536 | 3 |
iGMDRD945 | ML214 | 3 |
iGMDRD132 | (-)-gallocatechin-3-O-gallate | 3 |
iGMDRD219 | Bax channel blocker | 3 |
iGMDRD560 | MK-2206 | 2 |
iGMDRD670 | ML 210 | 2 |
iGMDRD424 | Tamatinib | 2 |
iGMDRD494 | Neopeltolide | 3 |
iGMDRD79 | Gemcitabine | 1 |
iGMDRD151 | CHM-1 | 3 |
iGMDRD433 | Lexibulin | 1 |
iGMDRD512 | nutlin 3 | 3 |
iGMDRD420 | Leucascandrolide A | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in PLK4